Genetic Technologies Ltd (GENE)
2.255
+0.03
(+1.42%)
USD |
NASDAQ |
May 03, 16:00
2.24
-0.01
(-0.65%)
After-Hours: 20:00
Genetic Technologies Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2008 | 0.0144 |
| March 31, 2008 | |
| December 31, 2007 | 0.0091 |
| September 30, 2007 | |
| June 30, 2007 | 0.0202 |
| March 31, 2007 | |
| December 31, 2006 | 0.0312 |
| September 30, 2006 |
| Date | Value |
|---|---|
| June 30, 2006 | 0.093 |
| March 31, 2006 | |
| December 31, 2005 | 0.00 |
| September 30, 2005 | |
| June 30, 2005 | 0.0904 |
| March 31, 2005 | |
| December 31, 2004 | 0.0412 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 0.00 |
| Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.74M |
| Total Liabilities (Quarterly) | 1.799M |
| Shareholders Equity (Quarterly) | 8.943M |